Publications
5532 Results
- Journal / Conference
- The Lancet 339(8784):1-5/71-85
- Year
- 1992
- Research Committee(s)
- Breast
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women.
- Journal / Conference
- Adjuvant Therapy of Cancer, SE Salmon (ed.)W.B. Saunders Co VI:529-542
- Year
- 1991
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-8291, SWOG-8391
Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10 year results and review of the literature.
- Journal / Conference
- Cancer 67(1):20-27
- Year
- 1991
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8092
A Southwest Oncology Group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer.
- Journal / Conference
- JCO 9(1):70-76
- Year
- 1991
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8110
A randomized trial of cis-platinum, vinblastine, and bleomycin vs. vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: A Southwest Oncology Group study.
- Journal / Conference
- IND 9:87-88
- Year
- 1991
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8304
Phase II study of L-Alanosine (NSC-153353) in patients with advanced breast cancer. A Southwest Oncology Group study.
- Journal / Conference
- AJCO 14(3):193-194
- Year
- 1991
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8320
Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer: A Southwest Oncology Group study.
- Journal / Conference
- IND 9:105-108
- Year
- 1991
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8324
Evaluation of fludarabine phosphate in malignant melanoma. A Southwest Oncology Group study.
- Journal / Conference
- IND 9:195-197
- Year
- 1991
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-8400/05
Phase II evaluation of fludarabine phosphate in patients with central nervous system tumors: A Southwest Oncology Group study.
- Journal / Conference
- IND 9:191-193
- Year
- 1991
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8408
Esorubicin in advanced endometrial cancer. An ineffective and potentially toxic therapy. A Southwest Oncology Group study.
- Journal / Conference
- EJCO 27(2):135-138
- Year
- 1991
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8500